본문으로 건너뛰기
← 뒤로

Zhilining formula suppresses ferroptosis in colonic epithelial cells by inhibiting ALOX15/15(S)-HPETE to repress colorectal tumorigenesis and progression.

Phytomedicine : international journal of phytotherapy and phytopharmacology 2026 Vol.150() p. 157687

Zhou R, Dai P, Li J, Guo C, Wang M, Liu F, Lin C, Zhu C

📝 환자 설명용 한 줄

[BACKGROUND] Ferroptosis has been established as a significant contributor to intestinal epithelial cell death, which potentially contributes to colorectal tumorigenesis and progression.

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Zhou R, Dai P, et al. (2026). Zhilining formula suppresses ferroptosis in colonic epithelial cells by inhibiting ALOX15/15(S)-HPETE to repress colorectal tumorigenesis and progression.. Phytomedicine : international journal of phytotherapy and phytopharmacology, 150, 157687. https://doi.org/10.1016/j.phymed.2025.157687
MLA Zhou R, et al.. "Zhilining formula suppresses ferroptosis in colonic epithelial cells by inhibiting ALOX15/15(S)-HPETE to repress colorectal tumorigenesis and progression.." Phytomedicine : international journal of phytotherapy and phytopharmacology, vol. 150, 2026, pp. 157687.
PMID 41411888

Abstract

[BACKGROUND] Ferroptosis has been established as a significant contributor to intestinal epithelial cell death, which potentially contributes to colorectal tumorigenesis and progression. Zhilining Formula (ZLN), composed of Andrographis herba (AH), Sophorae flavescentis radix (SFA), and Aucklandia radix (AR), possesses anti-inflammatory and intestinal barrier-protective effects. However, its effects and molecular mechanisms in colorectal cancer (CRC) remain unclear.

[OBJECTIVE] To investigate the effect of ZLN in CRC and elucidate its underlying molecular mechanism.

[METHODS] The therapeutic effect of ZLN on CRC was evaluated using an AOM/DSS-induced colitis to CRC progression mouse model. Time-series metabolomics mapped the metabolic network during disease progression, and characterize the regulatory effects of ZLN. Ferroptosis PCR array analysis was integrated to ascertain the mechanism by which ZLN mitigates colonic epithelial cells (CEC) ferroptosis. Further in vitro loss/gain-of-function cell and molecular biology experiments were conducted to elucidated the molecular mechanism of ZLN.

[RESULTS] ZLN significantly suppressed colorectal tumorigenesis and progression, accompanied by reduced inflammation and oxidative stress, and protected intestinal epithelial barrier in AOM/DSS-treated mice. An integrated analysis of the time-series metabolomics and ferroptosis PCR array revealed that the inhibition of lipid peroxidation induced by ALOX15/15(S)-HPETE represents a key mechanism through which ZLN reduces colonic epithelial cells (CEC) ferroptosis, thereby repressing colorectal tumorigenesis and progression. Besides, an in vitro Alox15 silencing/overexpression experiments confirmed that ZLN's inhibition of Alox15 effectively reduced CEC ferroptosis, and 15(S)-HPETE was identified as a trigger of CEC ferroptosis, with ZLN effectively counteracting its pro-ferroptosis effects.

[CONCLUSION] ZLN suppresses CEC ferroptosis by inhibiting ALOX15/15(S)-HPETE to repress colorectal tumorigenesis and progression, providing a rationale for employing ZLN as a potential therapeutic approach.

MeSH Terms

Ferroptosis; Animals; Arachidonate 15-Lipoxygenase; Colorectal Neoplasms; Mice; Humans; Epithelial Cells; Drugs, Chinese Herbal; Mice, Inbred C57BL; Arachidonate 12-Lipoxygenase; Carcinogenesis; Disease Progression; Male; Colon; Colitis; Disease Models, Animal

같은 제1저자의 인용 많은 논문 (5)